Literature DB >> 25472572

Icariin protects against intestinal ischemia-reperfusion injury.

Feng Zhang1, Yan Hu2, Xiaomei Xu2, Xiaohan Zhai2, Guangzhi Wang1, Shili Ning1, Jihong Yao2, Xiaofeng Tian3.   

Abstract

BACKGROUND: This study investigated the role of Sirtuin 1 (SIRT1)/forkhead box O3 (FOXO3) pathway, and a possible protective function for Icariin (ICA), in intestinal ischemia-reperfusion (I/R) injury and hypoxia-reoxygenation (H/R) injury.
MATERIALS AND METHODS: Male Sprague-Dawley rats were pretreated with different doses of ICA (30 and 60 mg/kg) or olive oil as control 1 h before intestinal I/R. Caco-2 cells were pretreated with different concentrations of ICA (25, 50, and 100 μg/mL) and then subjected to H/R-induced injury.
RESULTS: The in vivo results demonstrated that ICA pretreatment significantly improved I/R-induced tissue damage and decreased serum tumor necrosis factor α and interleukin-6 levels. Changes of manganese superoxide dismutase, Bcl-2, and Bim were also reversed by ICA, and apoptosis was reduced. Importantly, the protective effects of ICA were positively associated with SIRT1 activation. Increased SIRT1 expression, as well as decreased acetylated FOXO3 expression, was observed in Caco-2 cells pretreated with ICA. Additionally, the protective effects of ICA were abrogated in the presence of SIRT1 inhibitor nicotinamide. This suggests that ICA exerts a protective effect upon H/R injury through activation of SIRT1/FOXO3 signaling pathway. Accordingly, the SIRT1 activator resveratrol achieved a similar protective effect as ICA on H/R injury, whereas cellular damage resulting from H/R was exacerbated by SIRT1 knockdown and nicotinamide.
CONCLUSIONS: SIRT1, activated by ICA, protects intestinal epithelial cells from I/R injury by inducing FOXO3 deacetylation both in vivo and in vitro These findings suggest that the SIRT1/FOXO3 pathway can be a target for therapeutic approaches intended to minimize injury resulting from intestinal dysfunction.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; FOXO3; Icariin; Intestinal ischemia–reperfusion; Oxidative stress; SIRT1

Mesh:

Substances:

Year:  2014        PMID: 25472572     DOI: 10.1016/j.jss.2014.10.004

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  14 in total

Review 1.  Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2017       Impact factor: 1.990

Review 2.  The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Biochem Soc Trans       Date:  2018-03-09       Impact factor: 5.407

3.  Icariin protects cardiomyocytes against ischaemia/reperfusion injury by attenuating sirtuin 1-dependent mitochondrial oxidative damage.

Authors:  Bing Wu; Jian-Yu Feng; Li-Ming Yu; Yan-Chun Wang; Yong-Qing Chen; Yan Wei; Jin-Song Han; Xiao Feng; Yu Zhang; Shou-Yin Di; Zhi-Qiang Ma; Chong-Xi Fan; Xiao-Qin Ha
Journal:  Br J Pharmacol       Date:  2018-09-21       Impact factor: 8.739

Review 4.  Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2018       Impact factor: 1.990

5.  SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSION.

Authors:  Laura W Hansen; Adam Khader; Weng-Lang Yang; Jose M Prince; Jeffrey M Nicastro; Gene F Coppa; Ping Wang
Journal:  Shock       Date:  2016-04       Impact factor: 3.454

Review 6.  Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.

Authors:  Kenneth Maiese
Journal:  Expert Rev Clin Pharmacol       Date:  2020-01-03       Impact factor: 5.045

Review 7.  Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.

Authors:  Kenneth Maiese
Journal:  Neural Regen Res       Date:  2016-03       Impact factor: 5.135

8.  Forkhead transcription factors: new considerations for alzheimer's disease and dementia.

Authors:  Kenneth Maiese
Journal:  J Transl Sci       Date:  2016-06-14

9.  Protective effects of ginsenoside Rg1 on intestinal ischemia/reperfusion injury-induced oxidative stress and apoptosis via activation of the Wnt/β-catenin pathway.

Authors:  Guo Zu; Jing Guo; Ningwei Che; Tingting Zhou; Xiangwen Zhang; Guangzhi Wang; Xiaofeng Tian
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 10.  Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2021       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.